Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02955940 |
Title | An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Incyte Corporation |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Healthcare Hematology-Oncology | Santa Monica | California | 90404 | United States | Details | |
University of Louisville | Louisville | Kentucky | 40202 | United States | Details | |
New York Oncology Hematology Pc. | Clifton Park | New York | 12065 | United States | Details | |
Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
Renovatio Clinical | Houston | Texas | 77005 | United States | Details | |
University of Texas, Md Anderson Cancer | Houston | Texas | 77030 | United States | Details |